CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES ›› 2018, Vol. 36 ›› Issue (6): 552-559.

• Orginal Article • Previous Articles     Next Articles

Treatment of complicated hepatic alveolar echinococcosis: our experience of 98 cases

Xiao-lei XU1, Zhi-xin WANG1,2, Zhan WANG1,2, Hai-wen YE1, Ming-quan PANG1,2, Ying ZHOU1,2, Hai-jiu WANG1,2, Hai-ning FAN1,2,*()   

  1. 1 Department of Hepatopancreatobiliary Surgery, Affiliated Hospital of Qinghai University, Xining 810000, China
    2 Qinghai Province Key Laboratory of Hydatid Disease Research, Xining 810001, China
  • Received:2018-06-19 Online:2018-12-30 Published:2019-01-08
  • Contact: Hai-ning FAN E-mail:fanhaining@medmail.com.cn
  • Supported by:
    Supported by the National Key Research and Development Plan of China (No. 2017-YFC-0909900);Major Science and Technology Projects in Qinghai Province(No. 2016-SF-A5);Qinghai Medical and Health Science and Technology Project(No. 2016-wjtg-04)

Abstract:

ObjectiveTo explore the clinical treatment strategies for complicated hepatic alveolar echinococcosis and summarize treatment experiences. Methods A retrospective analysis was made on patients with complicated hepatic alveolar echinococcosis admitted to the Affiliated Hospital of Qinghai University from October 2015 to October 2017. According to the distribution of lesions, patients with advanced or mid-stage echinococcosis.were included in the study. Patients with hepatic cystic echinococcosis, early hepatic alveolar echinococcosis, and those treated with albendazole alone were excluded. According to the treatment design, they were divided into the quasi-radical surgical resection group (61 cases), the palliative surgical resection group(29 cases), and the liver transplantation group(8 cases). The operation duration, intraoperative blood loss, postoperative complications, and recurrence during follow-up were analyzed. Data were analyzed with SPSS 20.0. Results Ninety-eight patients were included in the study, including 40 males and 58 females (male to female ratio of 1 : 1.45). The patients aged 5 to 72 years, with an average age of 38 years. The incidence of postoperative complications in the quasi-radical resection group was 55.7% (34/61), including 18 cases of hypoproteinemia accompanied by pleural effusion, 9 with lung infection, 3 with incision infection, and 4 with bile leakage; the recurrence rate was 14.8% (9/61), and 3 died during follow-up. The incidence of postoperative complications in the palliative surgical resection group was 41.4%(12/29), including 5 with bile leakage complicated by residual cavity infection, 3 with pulmonary infection with pleural effusion, 2 with obstructive jaundice, 1 with incision infection, and 1 with bile duct-bronchial leak; the postoperative recurrence rate was 17.2% (9/29), and 3 died during follow-up. There was no significant difference in the postoperative complication incidence or recurrence rate between the quasi-radical resection group and the palliative resection group (P > 0.05), but a significant difference was found in the operation duration and blood loss (P < 0.05). Among the 8 patients who received liver transplantation, 4 died with 1 due to multiple organ failure after acute rejection, 2 gastrointestinal bleeding due to coagulopathy, and 1 hepatorenal syndrome, and the remaining 4 patients had long-term survival. Conclusion The treatment protocol for complicated hepatic alveolar echinococcosis needs to be individualized, in combination with multidisciplinary and highlighting damage control during surgery, in order to maximize patients' benefits.

Key words: Hepatic alveolar echinococcosis, Hepatectomy, Treatment

CLC Number: